Kosuke Inoue
@ki_endoepi
Followers
907
Following
227
Media
26
Statuses
402
Associate Prof: Kyoto Univ, Hakubi, L-Insight fellow, PhD: UCLA, Epidemiology, MD: Univ of Tokyo. Causal Inference, Endocrinology, CVD epi. JST Presto. IJE.
Kyoto, Japan
Joined May 2011
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Border Czar
• 568424 Tweets
Nigéria
• 210012 Tweets
Wolverine
• 164437 Tweets
Jasper
• 143647 Tweets
Newsweek
• 132668 Tweets
Nodal
• 73385 Tweets
Alberta
• 68518 Tweets
Padres
• 66103 Tweets
Marta
• 51881 Tweets
Lorena
• 42092 Tweets
スペイン
• 31999 Tweets
Fields
• 30300 Tweets
Bordeaux
• 23572 Tweets
renjun
• 21178 Tweets
#انصفوا_النصر_يالاستقطاب
• 14167 Tweets
Orioles
• 12717 Tweets
Dylan Cease
• 11813 Tweets
Gabi Nunes
• 11498 Tweets
Tuğba
• 11335 Tweets
Cancel Netflix
• 10423 Tweets
「#医学研究 のための #因果推論 レクチャー」が予約開始(4/8出版)されました！
読んでいただいた方が因果を考える・各手法の応用を���討する"きっかけ"になればという思いで執筆しました。本領域の良書が多く出版されている中、本書も選択肢の1つとして是非ご検討ください🙇♂️
3
43
208
昨年、東大・京大・ハーバード・UCLA・UoM・TXPなどで講演させていただいたHigh-benefit approachの研究が国際疫学会の公式雑誌IJEより出版されました。今後の個別化医療の議論に一石を投じることができたらと思います。
1
16
137
因果フォレストという機械学習モデルを用いて「誰をターゲットにCAC（冠動脈石灰化）スクリーニングを行うべきか」について議論した論文が、AHAでの発表に先立ち、Circulationから出版されました！今週Early Career Awardセッションで発表するのでシカゴにいる方は少し覗いていただけると嬉しいです🤗
2
7
59
フロントドア基準(FDF)を一般化し、医学研究に応用した論文を出版しました。FDFには因果推論の様々な思想が散りばめられているので、方法論に興味ある方は是非、eTextまで含めご一読いただけますと幸いです。日本語の簡単な解説についてはこちらをご覧ください。
Is there an effect of
#chronicpain
on death mediated through physicians’
#opioid
prescriptions💊?
To answer this public health question, we extended and applied a generalized form of
#FrontdoorFormula
in
@EpidemiologyLWW
.
@oacarah
@beate_ritz
(Thread) 1/
3
4
33
0
20
55
Our new paper
@IntJEpidemiol
showed that the high-benefit approach (treating🧍♀️with high estimated benefit) using
#ML
#CausalForest
outperformed the conventional high-risk approach (treating🧍with high risk) in BP management.
(thread) 1/
1
9
52
「因果推論・機械学習の疫学応用」というテーマで、篠崎先生
@she_knows_a_key
と原稿を書かせていただきました。TMLE・Causal forestについて簡単にまとめていますので興味ある方はご覧下さい。
0
15
49
Honored to receive MIT Technology Review's Innovators Under 35 Japan Award in 2023!! Hope the high-benefit approach will be one of the key strategies in the future precision medicine & public health era.
7
3
42
Exciting collaboration with
@_KSphs
!
Excited to announce our new paper in
@AmJEpi
! With
@ki_endoepi
, we discussed how causal forests (and other ML methods for estimating heterogeneous treatment effects) can advance research in population health and health equity, along with practical tips for its implementation.
1
16
73
0
6
34
Is there an effect of
#chronicpain
on death mediated through physicians’
#opioid
prescriptions💊?
To answer this public health question, we extended and applied a generalized form of
#FrontdoorFormula
in
@EpidemiologyLWW
.
@oacarah
@beate_ritz
(Thread) 1/
3
4
33
協会けんぽ第1弾：収入と腎機能低下の関連について検討しました。JAMA Health Forumより。京大SPH社会疫学の石村さんおめでとう！！
@HakubiProject
@univkyoto
@naoki_kondo
Our new
@JAMAHealthForum
study including 5.6 million adults in Japan found that adults in the lowest income decile showed increased risks of rapid
#CKD
progression and
#dialysis
initiation compared with the highest income decile.
#JHIA
@KyotoU_News
0
2
18
0
5
30
Our latest paper led by
@naito_tatsuhiko
(&
@okada_yukinori
& Oki-sensei & team!) is out in Circulation
@CircAHA
! Hope this
#GWAS
study advances our understanding and highlights the importance of
#PrimaryAldosteronism
-common
#endocrine
disorder as a cause of secondary
#HTN
.
0
4
28
In our new
@JAMANetworkOpen
paper, walking ≥8000 steps for 1-2 days/week showed a substantial mortality risk⬇️ as did those who were active more regularly🚶♀️.
2
5
26
協会けんぽ第2弾：パートナーがCVD発症した後にどの程度うつ病リスクが上昇するかについて検討しました。JAMA Network Openより。ボストン大SPHの古村さんおめでとう！！
@HakubiProject
@univkyoto
@KyotoU_News
Our new
@JAMANetworkOpen
study in Japan (277,142 matched pairs), we found an increased risk of depression associated with spouses’ onset of CVD, highlighting the need for household-level care.
#JHIA
@Yusuke_Tsugawa
@naoki_kondo
@justsato1111
1
4
18
0
4
23
I’m honored to receive an NIH F99/K00 transition award. This would not have been possible without the help of
@beate_ritz
,
@ER_Mayeda
, and Dr. Duru. I also appreciate heartful support from my mentors/collaborators around the world. So excited to keep working on this project.
4
0
22
Honored to present my research at Elizabeth Barrett-Connor Research Award session!
#AHA22
#EPI
Congratulations to all of our five presenters🎊 Here is a quick overview of my research simultaneously published in Circulation
@CircAHA
.
(thread) 1/
1
1
21
Japanese ver of ME4 is coming soon!
いよいよ疫学の聖書が日本語で出版されます。佐藤先生はじめ、監訳された先生方本当にお疲れ様でした🙇♂️！
『Modern Epidemiology, 4th edition』の邦訳『現代疫学』が5/30に出版されます！！！！
圧巻の1308ページ！！！！
カバーがかっこいい！！！！
Amazonページもできました（予約注文できるようになったらまた告知します）．
#モダンエピ
12
160
508
2
3
20
Our new research demonstrated the bias amplification feature of adjusting for a perfect/near- instrumental variable in
#gcomputation
under the time-varying settings.
@ki_endoepi
@she_knows_a_key
@naoki_kondo
Dr. Goto.
0
5
20
Our new
@JAMAHealthForum
study including 5.6 million adults in Japan found that adults in the lowest income decile showed increased risks of rapid
#CKD
progression and
#dialysis
initiation compared with the highest income decile.
#JHIA
@KyotoU_News
0
2
18
Our new
@JAMANetworkOpen
study in Japan (277,142 matched pairs), we found an increased risk of depression associated with spouses’ onset of CVD, highlighting the need for household-level care.
#JHIA
@Yusuke_Tsugawa
@naoki_kondo
@justsato1111
1
4
18
私を疫学の道へと導いてくださった後藤温先生（横市）と杉山雄大先生（NCGM）との共著です。執筆に際して、多くの先生方にご指導いただき、深く感謝しております！この場を借りて改めて御礼申し上げます。
2
3
18
井上浩輔 特定准教授（13期 医学研究科）の記事が京都大学広報誌『紅萠』第45号に掲載されました。
一人ひとりに恩恵を。AIを駆使して拓く医療戦略の新地平（コーナー：萌芽のきらめき・結実のとき）
@HakubiProject
@univkyoto
@ki_endoepi
0
4
8
2
3
17
We described increasing socioeconomic disparities in obesity prevalence among US adolescents. Collaboration work with
@Dr_KID_
& Roch, and great thread by our first author/rising star,
@Ryunosuke_Goto
1/ New research published in
@JAMAPediatrics
with Drs Roch Nianogo,
@Dr_KID_
, and
@ki_endoepi
! We evaluated the trends in adolescents' obesity prevalence by socioeconomic status in the US.
1
5
27
2
0
17
来年の米国疫学会SER
@Portland
(6/14-16)のTravel scholarshipの締切は12/9までです！日本在住で応募を検討されている学生・ポスドクは私までご連絡/DMいただけたら幸いです。今回は日本に焦点を当てたセッションも開催されますので、都合つく方は是非奮ってご参加下さい！
0
7
15
Wonderful time in LA & Chicago🇺🇸, huge thanks to my friends, colleagues, mentors, and family🙏
#SER2022
by
@societyforepi
was the best conference ever! Will come back soon✈︎
#UCLA
#LakeArrowhead
0
0
15
Our recent paper described the concept and application example of Generalizability & Transportability analysis for the general audience.
@ki_endoepi
@uclawillhsu
@oacarah
Ashley, Deni, and Alex.
0
4
14
Emphasized the importance of funding opportunities for early career researchers at Japanese-German University Presidents’ Conference (HeKKSaGOn). Even a small amount of money would be helpful to build international networks and start collaborations for larger projects in future!
1
1
14
NHK, 各社新聞、ネットニュースなど日米複数のメディアでも取り上げていただきました。暖かくなってきたのでぜひ週1日からでも歩いてみましょう🤗
In our new
@JAMANetworkOpen
paper, walking ≥8000 steps for 1-2 days/week showed a substantial mortality risk⬇️ as did those who were active more regularly🚶♀️.
2
5
26
1
1
12
Our recent work using
#NHANES
with
@AngelaLeung9
,
@beate_ritz
,
@ConnieMRhee
showed the
#CVD
#mediation
of the association between
#TSH
and mortality.
Cohort study finds even subclinical, mildly elevated TSH levels are associated with all-cause mortality, and cardiovascular disease mediates the association.
0
5
9
0
5
12
@DrDudenbostel
@HyperAHA
Thank you
@DrDudenbostel
,
@Hyper_AHA
, and all who attended this twitter live. This was so intense! I really enjoyed and learned a lot today!!
#HYPHIP
2
7
12
Congratulations
@oacarah
!! Our new president-elect
@societyforepi
. He is an amazing mentor, researcher, and leader!
Dr. Onyebuchi A. Arah (
@oacarah
),
#UCLAFSPH
professor of epidemiology, has been chosen as president-elect of the Society for Epidemiologic Research (
@societyforepi
).
Read more:
#epitwitter
11
10
85
1
0
12
@brandimwynne
@NakagawaPablo
@HyperAHA
@DrDudenbostel
The most challenging part would be to make clear temporality between these hormones and aldosterone when we tried to see some causal relationship between ald and CVD or CAC. But I would love to see them after this live!!
#HYPHIP
@HyperAHA
@DrDudenbostel
2
4
11
@fjorios
@HyperAHA
A12. Thank you! Yes, our mediation analysis showed that aldo may increase CVD in both pathways through BP and not through BP. Thus it would be really important to target aldo in addition to BP itself
#HYPHIP
@HyperAHA
@DrDudenbostel
1
6
11
Our
@JAMANetworkOpen
commentary with
@uclawillhsu
explores recent thought-provoking work on transportability analysis by Robertson et al.
#transportability
"Transportability Analysis—A Tool for Extending Trial Results to a Representative Target Population"
Interesting analysis in
@JAMANetworkOpen
showing estimated effects from NLST were similar when data was reweighted to match a nationally representative target population. Paper: Commentary on transportability methods w
@ki_endoepi
:
0
0
1
0
3
11
@DrDudenbostel
@HyperAHA
Also, I would love to give special thanks to
@TheEndoSociety
(SRF) & BWF fellowship which supported my work, my PhD mentors at
#UCLA
, and all MESA participants, collaborators, staff, and sponsors (including
#NIH
funding)!
#HYPHIP
@HyperAHA
@DrDudenbostel
@ki_endoepi
1
5
11
@DrDudenbostel
@fjorios
we did not see clear difference in BMI and urinary sodium between those with suppressed renin and unsuppressed renin. This is a little tricky because we are examining general population rather than PA patients
#HYPHIP
@HyperAHA
@DrDudenbostel
1
5
11
Our latest in
@IJEeditorial
with
@beate_ritz
@ER_Mayeda
@AGOTO_EPI
@ytsugawa1
@epi_vahe
and Drs. Nianogo, Telesca, Sugiyama, showed increased all-cause mortality risks among people with low HbA1c without DM. Careful monitoring may be needed for them.
#hba1c
#death
#gformula
A recent
@IJEeditorial
article uses
#g
-formulas and
#machine
learning to examine low
#HbA1c
levels and all-cause or
#cardiovascular
#mortality
among people without
#diabetes
:
#NHANES
@ki_endoepi
@beate_ritz
0
2
8
0
4
11
@DrDudenbostel
@HyperAHA
A1-3. In our study, we found that aldosterone was associated with increased risk of subclinical CVD (i.e., higher CAC) and death particularly when renin was suppressed. Moreover, around 45% of this association was mediated by BP↑.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
6
11
@NakagawaPablo
@HyperAHA
@DrDudenbostel
A14-3. Thus, the question I have is "is the current clinical practice for PA enough to detect people who will have damage due to autonomous aldo secretion?" Will we need to cover more patients (including subclinical PA or even more?).
#HYPHIP
@HyperAHA
@DrDudenbostel
1
5
10
@brandimwynne
@HyperAHA
@DrDudenbostel
A7. Interesting question. No, I haven't, but will look at whether we see the associations if variables seem to be available. Thank you!
#HYPHIP
@HyperAHA
@DrDudenbostel
1
3
10
@DrDudenbostel
@HyperAHA
A4-3. Thus, before our study, we needed more evidence as to whether aldosterone also plays an important role in CVD pathogenesis among general adults (even without PA or essential HTN).
#HYPHIP
@HyperAHA
@DrDudenbostel
0
5
10
@DrDudenbostel
@HyperAHA
A11-1. In general, renin (at least partially) regulates aldo secretion in
#RAAS
, thus low renin & high aldo indicates autonomous secretion of aldo independent of renin (and suppress renin through negative feedback system)
#HYPHIP
@HyperAHA
@DrDudenbostel
2
5
10
@NakagawaPablo
@HyperAHA
@DrDudenbostel
A14-2. At the same time, before jumping to treatment strategy, I think we need more evidence about who we need to think about treatment targeting aldo (e.g., MR)
#HYPHIP
@HyperAHA
@DrDudenbostel
1
5
10
@frank_spradley
@DrDudenbostel
@HyperAHA
A9. I am not familiar with this topic, but probably this might be helpful (). I need to search more though, sorry!
#HYPHIP
@HyperAHA
@DrDudenbostel
1
5
10
@DrDudenbostel
@HyperAHA
Hi all, I am a physician-scientist at
#KyotoUniv
and
#UCLA
. My background is an
#endocrinologist
(
#UnivTokyo
) who loves
#adrenal
and
#thyroid
glands, and now specializes in
#causal
modeling in clinical epidemiology as an epidemiologist.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
8
10
@DrDudenbostel
@HyperAHA
A1-2. Thus, we investigated the association between Aldo and CAC/death. Given the direct and indirect organ damage of aldo↑, we also estimated the extent to which BP↑ mediated the association.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
6
10
@DrDudenbostel
@HyperAHA
A4-2. Aldo↑ is associated with many kinds of CVD including heart failure, coronary artery disease, and stoke. However, most of the previous studies have been investigated among people with primary aldosteronism (PA) or essential HTN.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
7
10
@DrDudenbostel
A3. MESA is a multicenter longitudinal cohort study of adults (45-84 years) free of CVD from 6 communities in the US. Its main goals include the identification of the risk factors for clinical and subclinical CVD progression.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
4
10
@NakagawaPablo
@HyperAHA
@DrDudenbostel
A10. Base on previous studies, I assume aldo this is not specific to CAC. It would also related to calcification of other arteries but not aware of studies on this topic about people without PA.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
5
10
@fjorios
@HyperAHA
A5-1. PA is not a deterministic disorder, and there are people who are between PA and non-PA (including subclinical PA).
#HYPHIP
@HyperAHA
@DrDudenbostel
1
3
10
@DrDudenbostel
@HyperAHA
A4-1. Aldo is an essential hormone regulating sodium reabsorption, water retention, and BP. Thus, inappropriately aldo↑ can increase BP, Moreover, excessive stimulation of mineralocorticoid receptor increases CVD risks independent of BP↑.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
5
10
Our new research using MESA with the amazing team at UCLA showed the association between elevated urinary stress hormones and incident hypertension/CVD events. Findings highlight the critical role of stress hormones in the pathogenesis of HTN.
1
0
10
@NakagawaPablo
@HyperAHA
A14-1. Really important point. We can make our findings close to causation using some causal modeling, but it does not tell causality because this is still obs data and suffer from many biases.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
4
10
@DrDudenbostel
@HyperAHA
A20-2. I am also interested in identifying who we really need to consider treatment/intervention for aldo↑ to prevent CVD (i.e., heterogeneous treatment effects). Any advice & collaboration would be greatly appreciated!!
#HYPHIP
@HyperAHA
@DrDudenbostel
1
6
9
@guto_montezano
@DrDudenbostel
@HyperAHA
A6-1. Yes, CAC is "coronary artery calcium" and one of the major markers of subclinical cardiovascular disease.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
4
9
@DrDudenbostel
@HyperAHA
A11-2. This is one of the major characteristics of primary aldosteronism (PA), the common type of secondary hypertension. Recently, the spectrum of subclinical PA has been established for normotensive persons ().
#HYPHIP
@HyperAHA
@DrDudenbostel
1
4
9
Honored to receive a paper award from
@uja_info
(United Japanese Researchers Around the World)!
A short presentation will be on May 8th, 10am JST.
#UJA
論文賞2022
#Aldosterone
#MediationAnalysis
0
1
9
Lovely figures to describe basic rules of DAG🏃♂️
@ki_endoepi
@AGOTO_EPI
今回は，因果関係に関する仮説を整理する上で有用なアプローチである「DAG」を解説します。図解された基本事項と具体例を元に，変数の調整を考えていきましょう。
週刊医学界新聞［連載］臨床研究・疫学研究のための因果推論レクチャー（3）（井上浩輔，杉山雄大，後藤温）
0
66
296
0
2
9
@DrDudenbostel
@HyperAHA
A20-1. Because the present study used a single point of aldo measurements, I am very interested in further investigating the possible cardiovascular burden of dynamic change in aldo (and other hormones) over time.
#HYPHIP
@HyperAHA
@DrDudenbostel
2
6
9
AMAZING time to discuss our paper about
#aldo
and
#CAC
using
#mediation
analysis!. Thank you so much for this great opportunity. I learned a lot!!
#HYPHIP
@HyperAHA
@DrDudenbostel
@ki_endoepi
Today’s fantastic chat is complete and on behalf of
@HyperAHA
#SoMe
Editor team we thank
@ki_endoepi
for a great discussion and for joining us today! Good luck with ongoing research & we look forward to seeing you join us again for
#HYPHIP
1
7
16
0
7
9
@Carmendemigue12
@HyperAHA
A21-1. Given that we see the sex difference particularly among adults<60 yrs (Table S1), we assume this difference might be attributed at least in part to difference in sex hormones (i.e. protective effect of estrogen).
#HYPHIP
@HyperAHA
@DrDudenbostel
1
5
9
@Carmendemigue12
@HyperAHA
@DrDudenbostel
A22-2. Also the sensitive to mineralocorticoid receptor may also differ by sex, but definitely further epidemiological and biological studies are needed to understand the potential sex heterogeneity.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
5
9
@NakagawaPablo
@HyperAHA
A15-1. I agree with your idea. Although we did not use the measurement of arterial stiffness (e.g., PWV) in our study, several studies have already investigated the association particularly among hypertensive patients, as you know
#HYPHIP
@HyperAHA
@DrDudenbostel
1
4
9
明日です。興味ある方はご笑覧下さい🤗
【イベント情報】
KURA共催でシンポジウム「若手研究者の海外留学・海外転職、再考--パンデミック後の研究キャリア選択」を2023年1月27日（金）に対面・オンライン同時進行のハイブリッド形式で開催します📢
詳細・お申込みはこちらから（要予約）👇
0
2
14
0
0
9
@guto_montezano
@DrDudenbostel
@HyperAHA
ample evidence has shown the relationship between CAC and CVD. e.g.,
#HYPHIP
@HyperAHA
@DrDudenbostel
0
4
9
@DrDudenbostel
@HyperAHA
A1-1. It has been well known that aldosterone has a key role in the pathogenesis of CVD, but the evidence as to the long-term health outcomes of aldo↑ had been limited particularly among the general population.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
6
9
Are physicians who receive industry marketing payments for high-cost 🫀drugs like
#PCSK9i
more likely to prescribe the drugs? Is the sky blue (on average)?
We offer a nuanced take on this controversial topic in
@CircOutcomes
.
(thread) 1/
1
3
9
@brandimwynne
@NakagawaPablo
@HyperAHA
Yes, these topics are really important but were a little beyond the scope of this study.
#HYPHIP
@HyperAHA
@DrDudenbostel
1
4
9
Our new research w/
@liew_zeyan
(PI),
@beate_ritz
and amazing collaborators in Denmark finds some gestational-week–specific associations between PFAS and TSH in early pregnancy.
@EHPonline
.
Credits go to
@Koinoue1989
, a talented endocrinologist and a PhD candidate in epidemiology
@UCLAFSPH
@beate_ritz
and the DNBC teams in Denmark
@AarhusUni
@dceaarhus
.
1
0
6
1
1
8
@NakagawaPablo
@HyperAHA
@DrDudenbostel
A15-2. Given a recent meta-analysis of RCT showed the benefit of MR blocker on arterial stiffness (suggesting the critical role of aldo on arterial stiffness (), I believe this mechanism would explain a part of our findings.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
3
8
@DrDudenbostel
@HyperAHA
A19-3. Not sure about Asian Americans, but ample evidence has shown the CVD burden of aldo↑ among Asians. Thus, I hypothesize that our findings may be applied to all of these racial/ethnic groups but need more studies to validate my hypothesis.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
5
8
@DrDudenbostel
@HyperAHA
A19-1. A previous MESA study () showed that AA/Black individuals had lower aldo and Hispanics had higher renin. They also showed the association between aldo and SBP only among Hispanics.
#HYPHIP
@HyperAHA
@DrDudenbostel
2
5
8
@fjorios
@HyperAHA
@DrDudenbostel
A5-2. Thus we assume some people maynot have PA diagnosis, but mild autonomous aldosterone secretion.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
4
8
@AnastasiaSMihai
@HyperAHA
@DrDudenbostel
A16. Yes! We analyzed serum aldosterone concentrations.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
3
8
@DrDudenbostel
@HyperAHA
A19-2. Meanwhile, the Jackson Heart Study (a cohort of AA/Black individuals) showed the association of aldo↑ with SBP (), CVD, and death ().
#HYPHIP
@HyperAHA
@DrDudenbostel
2
5
8
Our new paper linking industry payments with physicians' prescription of insulin was just published in
@PLOSMedicine
!
Hope this will advance the discussion about the insulin affordability crisis in the US.
@ki_endoepi
@yusuke_tsugawa
@CMM_UCLA
@OKenrik
0
0
8
大学時代からの親友、内藤先生とメンターの岡田先生、鯉党×内分泌で昔からお世話になっている沖先生との共同研究がCirculationから出版されました！臨床・研究に深く携わってきた原発性アルドステロン症の病態解明に貢献することができ光栄です。
プレスリリースはこちら：
Our latest paper led by
@naito_tatsuhiko
(&
@okada_yukinori
& Oki-sensei & team!) is out in Circulation
@CircAHA
! Hope this
#GWAS
study advances our understanding and highlights the importance of
#PrimaryAldosteronism
-common
#endocrine
disorder as a cause of secondary
#HTN
.
0
4
28
0
0
6
@DrDudenbostel
@HyperAHA
@TheEndoSociety
Lastly, this work could not have been done and published without huge help and support from Dr. Watson
@kewatson
, Dr. Allison, Dr. Goldwater, Dr. Seeman, and Dr. Kestenbaum,. Thank you so much!!
#HYPHIP
@HyperAHA
@DrDudenbostel
0
3
7
Honored to contribute to this prestigious journal in clinical endocrinology. Thank you very much,
@vtangpricha
, and all editorial staff of
#EndocrinePractice
!
Thank you top reviewers of
#EndocrinePractice
including
@dclieb
@AngelaLeung9
@ki_endoepi
Drs Barzilay, Ospina, Lansang, Szalat, Guan, and Grajower
0
3
11
0
0
7
@fjorios
@HyperAHA
A18. Yes, our data include many people with aldo within the reference range but renin suppressed. Increased CAC even among these people is important for our reconsideration of "what the reference range is" for this nasty hormone.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
4
7
@asouth_neph
@fjorios
@HyperAHA
@DrDudenbostel
Thank you,
@asouth_neph
!! Yes, one of my PhD thesis topics was how to implement causal modeling (particularly
#MediationAnalysis
) in clinically important research questions (related to endo and CVD).
#HYPHIP
@HyperAHA
@DrDudenbostel
1
4
6
Marvelous work by
@YMcardio
at
#AHA22
with publication in
@TheEndoSociety
# JCEM. In this meta-analysis,
#SGLT2i
were associated with incident
#T2DM
risk⬇️among
#prediabetes
with
#HF
or
#CKD
. SGLT2i might be useful in preventing
#DM
among such high-risk populations.
@univkyoto
Our recent work was published from
#JCEM
@EndoSocJournals
!. Also presented in
#AHA22
.
Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: Systematic Review and Meta-analysis of Randomized Controlled Trials
0
4
4
1
0
6
@brandimwynne
@NakagawaPablo
@HyperAHA
A17. We did not analyze the data, but given the weak or null association between aldo and pulse pressure in PA patients, I would assume there won't be significant difference.
#HYPHIP
@HyperAHA
@DrDudenbostel
0
4
6
Congratulations
@ER_Mayeda
!!
2020 Brian MacMahon Early Career Award Winner Elizabeth Rose Maveda
@ER_Mayeda
is an assistant professor of epidemiology at
@UCLA
. Her research interests include racial, ethnic, and other social inequalities in Alzheimer’s disease and methods. Award sponsored by
@HarvardChanSPH
.
2
2
21
1
0
6
Congratulations on this great achievement Dr. Ritz
@beate_ritz
! She has been a wonderful advisor and helped me a lot to build a career path as an epidemiologist. I was so lucky to be her advisee at
@UCLAFSPH
Congratulations to
#SER2022
Kenneth Rothman Career Accomplishment Award Winner
@beate_ritz
from
@UCLAFSPH
! Award sponsored by
@BUSPH
0
8
53
0
0
6
@DrDudenbostel
@HyperAHA
Thank you very much
@DrDudenbostel
and
@HyperAHA
for giving me such a great opportunity!! Looking forward to the discussion about our paper today!
#HYPHIP
0
4
6
@georgehret
@HyperAHA
@DrDudenbostel
A2. This is a great point. MESA (the cohort we used for this study) has a standardized protocol to measure CAC.
0
2
5
@guto_montezano
@DrDudenbostel
@HyperAHA
A13. Sorry, I don't have the answer to this. Let me check this after this live and will let you know!
1
0
5
Excited to learn/improve "global insight" with great mentors and colleagues as L-INSIGHT fellow
@KyotoU_News
over the next several years!
#LINSIGHT
3
0
5
Farewell ceremony for
#Hakubi
researchers 2023. Very inspiring 7 talks!! Congratulations to all presenters & thanks to all attendees.
@HakubiProject
0
0
5